← Back to Search

Multifocal Contact Lenses for Accommodation Disorder

N/A
Recruiting
Led By Ann M Morrison, OD, PhD
Research Sponsored by Ohio State University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
No history of ocular disease or active ocular inflammation
Free of binocular vision disorder (strabismus, amblyopia, vergence dysfunction, accommodative dysfunction)
Timeline
Screening 3 weeks
Treatment Varies
Follow Up up to two hours
Awards & highlights

Study Summary

This trial aims to determine how soft multifocal contact lenses affect presbyopic vision and accommodative & binocular vision disorders. They are designed to provide a range of clear vision at both distance and near by introducing a power gradient over the eye. Results will help us understand if center near designs provide a greater therapeutic effect for these disorders.

Who is the study for?
This trial is for individuals aged 18 to 30 with good vision (20/25 or better) in both eyes using their current contact lenses. They should have no eye diseases, surgeries, rigid lens wear, significant astigmatism (>1.00 D), or binocular vision disorders. Participants must not be on treatments affecting myopia control or accommodation.Check my eligibility
What is being tested?
The study tests how center near and center distance multifocal contact lenses affect accommodative function in young adults. It aims to determine if these lenses can help manage issues like difficulty focusing on close objects by comparing the effectiveness of different lens designs.See study design
What are the potential side effects?
While the trial doesn't explicitly mention side effects, typical ones from wearing contact lenses may include eye discomfort, dryness, redness, blurred vision, and a feeling of something in the eye.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I have no history of eye diseases or current eye inflammation.
Select...
I do not have any disorders affecting my ability to see clearly with both eyes.
Select...
I have never had eye surgery.
Select...
I am between 18 and 30 years old.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~up to two hours
This trial's timeline: 3 weeks for screening, Varies for treatment, and up to two hours for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Objective Accommodative Outcome
Secondary outcome measures
Accommodation Clinical Measures
Vergence Clinical Measures

Trial Design

2Treatment groups
Experimental Treatment
Group I: Center Near Multifocal Contact LensExperimental Treatment1 Intervention
All participants will wear a Biofinity center near multifocal contact lens with a +2.50 add and measurements will be obtained.
Group II: Center Distance Multifocal Contact LensExperimental Treatment1 Intervention
All participants will wear a Biofinity center distance multifocal contact lens with a +2.50 add and measurements will be obtained.

Find a Location

Who is running the clinical trial?

Ohio State UniversityLead Sponsor
830 Previous Clinical Trials
505,600 Total Patients Enrolled
Ann M Morrison, OD, PhDPrincipal InvestigatorOhio State University
1 Previous Clinical Trials
35 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

What criteria should potential participants meet to be eligible for this research?

"To be eligible for this trial, patients must demonstrate a diagnosis of accommodation disorder and fall between the ages of 18 to 30. This study will accept 20 participants in total."

Answered by AI

Are individuals of a youthful age being included in this trial?

"As stipulated in the study guidelines, individuals between 18 and 30 years of age may elect to join this clinical trial."

Answered by AI

Are more participants currently being sought out for this clinical experiment?

"As indicated on clinicaltrials.gov, this trial is not presently enrolling participants. Initially posted in October of 2023 and last updated on September 26th of the same year, recruiting efforts have been suspended for now; however, there are one other trials actively seeking patients at this time."

Answered by AI
~12 spots leftby Dec 2024